Literature DB >> 19449188

Polymorphisms in PDCD1 gene are not associated with Wegener's granulomatosis.

Priya Sakthivel1, Ricardo Giscombe, Ryan Ramanujam, Ann Kari Lefvert.   

Abstract

Genetic association of programmed cell death-1 (PDCD1) has been implicated in several autoimmune inflammatory disorders. Hence, in this study, our main objective is to evaluate the association of PDCD1 gene to Wegener's granulomatosis (WG). We, thus, analyzed three single nucleotide polymorphisms (SNPs) in PDCD1 gene among WG patients and controls. Further, we quantified circulating serum levels of soluble (s) PD-1 in patients and controls. The methodologies used were ABI Taqman allelic discrimination and restriction fragment length polymorphism for genotyping and in-house ELISA for quantifying sPD-1. Statistical relevance was analyzed by Fischer's exact test. As a result, reduced AA homozygote for SNP in intron-1 was observed, among the patients. However, no association was demonstrated after Bonferroni correction. Also, no differences in genotype and allele frequency were elucidated for SNPs in intron-4 and exon-5. Moreover, we could not demonstrate circulating sPD-1. In conclusion, we show no association of selected SNPs in PDCD1 gene with WG.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19449188     DOI: 10.1007/s00296-009-0952-1

Source DB:  PubMed          Journal:  Rheumatol Int        ISSN: 0172-8172            Impact factor:   2.631


  18 in total

1.  Differential B- and T-cell activation in Wegener's granulomatosis.

Authors:  E R Popa; C A Stegeman; N A Bos; C G Kallenberg; J W Tervaert
Journal:  J Allergy Clin Immunol       Date:  1999-05       Impact factor: 10.793

2.  Alternative splice variants of the human PD-1 gene.

Authors:  Christian Nielsen; Line Ohm-Laursen; Torben Barington; Steffen Husby; Søren T Lillevang
Journal:  Cell Immunol       Date:  2005-09-19       Impact factor: 4.868

3.  Positive and negative regulation of human T cell activation mediated by the CTLA-4/CD28 ligand CD80.

Authors:  G Boulougouris; J D McLeod; Y I Patel; C N Ellwood; L S Walker; D M Sansom
Journal:  J Immunol       Date:  1998-10-15       Impact factor: 5.422

4.  Aberrant regulation of synovial T cell activation by soluble costimulatory molecules in rheumatoid arthritis.

Authors:  Bing Wan; Hong Nie; Ailian Liu; Guozhang Feng; Dongyi He; Rong Xu; Qi Zhang; Chen Dong; Jingwu Z Zhang
Journal:  J Immunol       Date:  2006-12-15       Impact factor: 5.422

5.  PD-L2 is a second ligand for PD-1 and inhibits T cell activation.

Authors:  Y Latchman; C R Wood; T Chernova; D Chaudhary; M Borde; I Chernova; Y Iwai; A J Long; J A Brown; R Nunes; E A Greenfield; K Bourque; V A Boussiotis; L L Carter; B M Carreno; N Malenkovich; H Nishimura; T Okazaki; T Honjo; A H Sharpe; G J Freeman
Journal:  Nat Immunol       Date:  2001-03       Impact factor: 25.606

6.  Coding sequence 1 and promoter single nucleotide polymorphisms in the CTLA-4 gene in Wegener's granulomatosis.

Authors:  Ricardo Giscombe; Xiongbiao Wang; Deren Huang; Ann Kari Lefvert
Journal:  J Rheumatol       Date:  2002-05       Impact factor: 4.666

Review 7.  Pathogenesis of Wegener's granulomatosis.

Authors:  W L Gross; A Trabandt; E Csernok
Journal:  Ann Med Interne (Paris)       Date:  1998-09

8.  Association of the PD-1.3A allele of the PDCD1 gene in patients with rheumatoid arthritis negative for rheumatoid factor and the shared epitope.

Authors:  Ludmila Prokunina; Leonid Padyukov; Anna Bennet; Ulf de Faire; Björn Wiman; Jonathan Prince; Lars Alfredsson; Lars Klareskog; Marta Alarcón-Riquelme
Journal:  Arthritis Rheum       Date:  2004-06

9.  Association of a putative regulatory polymorphism in the PD-1 gene with susceptibility to type 1 diabetes.

Authors:  C Nielsen; D Hansen; S Husby; B B Jacobsen; S T Lillevang
Journal:  Tissue Antigens       Date:  2003-12

10.  CD28 and CTLA-4 have opposing effects on the response of T cells to stimulation.

Authors:  M F Krummel; J P Allison
Journal:  J Exp Med       Date:  1995-08-01       Impact factor: 14.307

View more
  5 in total

1.  Polymorphisms in PDCD1 gene are not associated with aplastic anemia in Chinese Han population.

Authors:  Z J Ming; H Hui; M Miao; Y H Qiu; X G Zhang
Journal:  Rheumatol Int       Date:  2011-09-17       Impact factor: 2.631

2.  Vasculitis associated with immune checkpoint inhibitors-a systematic review.

Authors:  Anisha Daxini; Keri Cronin; Antoine G Sreih
Journal:  Clin Rheumatol       Date:  2018-06-19       Impact factor: 2.980

Review 3.  Epidemiology and genetics of granulomatosis with polyangiitis.

Authors:  Pratibha Banerjee; Arushi Jain; Uma Kumar; Sabyasachi Senapati
Journal:  Rheumatol Int       Date:  2021-10-11       Impact factor: 2.631

Review 4.  Cardiovascular Toxicity of Immune Checkpoint Inhibitors: Clinical Risk Factors.

Authors:  Flora Pirozzi; Remo Poto; Luisa Aran; Alessandra Cuomo; Maria Rosaria Galdiero; Giuseppe Spadaro; Pasquale Abete; Domenico Bonaduce; Gianni Marone; Carlo Gabriele Tocchetti; Gilda Varricchi; Valentina Mercurio
Journal:  Curr Oncol Rep       Date:  2021-01-07       Impact factor: 5.075

Review 5.  Delicate Role of PD-L1/PD-1 Axis in Blood Vessel Inflammatory Diseases: Current Insight and Future Significance.

Authors:  Priya Veluswamy; Max Wacker; Maximilian Scherner; Jens Wippermann
Journal:  Int J Mol Sci       Date:  2020-10-31       Impact factor: 5.923

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.